A PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF OBINUTUZUMAB BENDAMUSTINE TREATMENT IN PATIENTS WITH RELAPSED /REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA.

Authors :: García‐Marco, J.
Baltasar Tello, P.
Gonzalez Garcia, E.
Ríos Herranz, E.
Ramírez Payer, Á.
Terol Castera, M.
Champ, D.
Medina Pérez, Á.
Gironella Mesa, M.
Rodríguez Fernández, A.
Muntañola Prat, A.
Suárez Cabrera, A.
Puerta Puerta, J.
Fernández Zarzoso, M.
Rodríguez Calvillo, M.
Clavel Piá, J.
Dourdil Sahun, V.
Ferrá Coll, C.
Pérez Persona, E.
Marrero Santos, C.
Source :: Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p380-382, 3p
Publication Year :: 2019

Full Text Access

Tools